Page last updated: 2024-10-21

3-aminobenzamide and Chronic Disease

3-aminobenzamide has been researched along with Chronic Disease in 1 studies

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jijon, HB1
Churchill, T1
Malfair, D1
Wessler, A1
Jewell, LD1
Parsons, HG1
Madsen, KL1

Other Studies

1 other study available for 3-aminobenzamide and Chronic Disease

ArticleYear
Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis.
    American journal of physiology. Gastrointestinal and liver physiology, 2000, Volume: 279, Issue:3

    Topics: Animals; Benzamides; Chronic Disease; Colitis; Disease Models, Animal; Energy Metabolism; Enzyme Inh

2000